Marker Therapeutics, Inc. (MRKR)

Marker Therapeutics Statistics

Total Valuation

MRKR has a market cap or net worth of $19.70 million. The enterprise value is $10.70 million.

Market Cap	19.70M
Enterprise Value	10.70M

Important Dates

The next estimated earnings date is Tuesday, March 25, 2025, after market close.

Earnings Date	Mar 25, 2025
Ex-Dividend Date	n/a

Share Statistics

MRKR has 10.71 million shares outstanding. The number of shares has increased by 2.63% in one year.

Current Share Class	10.71M
Shares Outstanding	10.71M
Shares Change (YoY)	+2.63%
Shares Change (QoQ)	+0.06%
Owned by Insiders (%)	10.17%
Owned by Institutions (%)	8.98%
Float	7.99M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.04
Forward PS	4.83
PB Ratio	2.20
P/TBV Ratio	2.64
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	1.98
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.15

Current Ratio	3.15
Quick Ratio	2.82
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -79.76% and return on invested capital (ROIC) is -52.75%.

Return on Equity (ROE)	-79.76%
Return on Assets (ROA)	-41.92%
Return on Invested Capital (ROIC)	-52.75%
Return on Capital Employed (ROCE)	-136.85%
Revenue Per Employee	$674,481
Profits Per Employee	-$1.21M
Employee Count	8
Asset Turnover	0.36
Inventory Turnover	n/a

Taxes

In the past 12 months, MRKR has paid $3,675 in taxes.

Income Tax	3,675
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -57.80% in the last 52 weeks. The beta is 1.49, so MRKR's price volatility has been higher than the market average.

Beta (5Y)	1.49
52-Week Price Change	-57.80%
50-Day Moving Average	3.14
200-Day Moving Average	3.73
Relative Strength Index (RSI)	32.34
Average Volume (20 Days)	75,833

Short Selling Information

The latest short interest is 193,412, so 1.81% of the outstanding shares have been sold short.

Short Interest	193,412
Short Previous Month	110,755
Short % of Shares Out	1.81%
Short % of Float	2.42%
Short Ratio (days to cover)	1.55

Income Statement

In the last 12 months, MRKR had revenue of $5.40 million and -$9.70 million in losses. Loss per share was -$1.09.

Revenue	5.40M
Gross Profit	-5.60M
Operating Income	-10.19M
Pretax Income	-5.66M
Net Income	-9.70M
EBITDA	n/a
EBIT	-10.19M
Loss Per Share	-$1.09

Balance Sheet

Cash & Cash Equivalents	9.00M
Total Debt	n/a
Net Cash	9.00M
Net Cash Per Share	$0.84
Equity (Book Value)	7.45M
Book Value Per Share	0.83
Working Capital	7.45M

Cash Flow

Operating Cash Flow	-8.57M
Capital Expenditures	n/a
Free Cash Flow	-8.57M
FCF Per Share	-$0.80

Margins

Gross margin is -103.84%, with operating and profit margins of -188.94% and -179.71%.

Gross Margin	-103.84%
Operating Margin	-188.94%
Pretax Margin	-178.47%
Profit Margin	-179.71%
EBITDA Margin	n/a
EBIT Margin	-188.94%
FCF Margin	n/a

Dividends & Yields

MRKR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.63%
Shareholder Yield	-2.63%
Earnings Yield	-49.22%
FCF Yield	-43.52%

Analyst Forecast

The average price target for MRKR is $19.00, which is 932.61% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$19.00
Price Target Difference	932.61%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	84.94%
EPS Growth Forecast (5Y)	5.37%

Stock Splits

The last stock split was on January 27, 2023. It was a reverse split with a ratio of 0.1:1.

Last Split Date	Jan 27, 2023
Split Type	Reverse
Split Ratio	0.1:1

Scores

MRKR has an Altman Z-Score of -52.49 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-52.49
Piotroski F-Score	3